History of IECP.Learn More About it.

History of IECP

The History of IECP
It is really fascinating and hard to believe that external counterpulsation (ECP) was being performed as early as the 12th Century in Ancient India, and nowadays with high technology equipment. The only difference was that in fact, it was an early form of Yogi, which was actioned by mire contraction of the abdominal muscles and nowadays is known as Kapalbhati.


We will try and find out more about Kapalbhati and what the claims are?


 

  • Kapalbhati is one of the most beneficial pranayamas and has been proven to be effective in several disorders, that includes helping to control diabetes mellitus by stimulating the pancreas, thus increasing the release of insulin.
  • Kapalbhati has been effective with various liver disorders and there have been various cases, where in the case of chronic liver diseases there have been significant improvements. In addition to that, it has increased the survival rate of blood cancers and other tumours. 
  • Kapalbhati has been seen to give improvements in sexual function and has been beneficial for infertility too. The two most common and important causes of infertility are blockage of the fallopian tube in females and oligospermia in males, Kapalbhati is helpful with both.
  • Kapalbhati is beneficial in common abdominal problems and controls indigestion, constipation and has also been shown to be effective in helping with Irritable Bowel Syndrome, (IBS).
  • Kapalbhati purifies blood circulation by aerating it and has been extremely beneficial in helping with several chronic skin disorders like psoriasis, eczema, allergies, leucoderma, vitiligo and even acne.
  • Several mental disorders including anxiety, depression and even schizophrenia had been cured by this asana.

 

POLICY/CRITERIA
Effects of Kapalbhati are considered investigational for the treatment of all conditions, including but not limited to diabetes mellitus and erectile dysfunction.

POSITION SUMMARY
The evidence is not sufficient to permit conclusions about the benefits of Kapalbhati as a treatment for any condition.
It is uncertain whether true Kapalbhati offers any additional effectiveness as the standard treatment options in yoga currently available to patients with diabetes mellitus and erectile dysfunction.

Benefits

No definite clinical findings are available about the above benefits, and no trials were ever carried out in the world to justify the above claims. Today, though, millions of people are doing just this and claiming benefits. In 2006, we started studying the benefits of this Yoga exercise and how it could have possible benefits for diabetes mellitus.

The technic of Kapalbhati is to contract the abdominal muscles in quick succession, typically between 60 to 80 times in a minute. The sudden contraction of the abdominal muscle, the rectus abdominous momentarily compressed the renal veins, inferior vena cava, abdominal aorta artery, posterior vena cava and iliac vein.

We started studying randomly the effectiveness of this exercise on patients with type-1 and type-2 diabetes. The exercise was carried out 2 times every morning and evening on an empty stomach. The blood sugar levels of all the patients came down by an average of 40 points in 10 days.

At the end of three months trial period it was found that the sugar levels remained controlled, but this was due to the exercise associated with the process and most of the patients had lost between 3 and 5 kg in weight. This was not a cure for diabetes mellitus as was claimed, but the patients claimed of being much more active and energetic.

Subsequent analysis of the participants demonstrated statistically significant changes of both their exercise duration and peak oxygen consumption. Could this have some effect on cardiac insufficiency patients? So with this in mind, a group of five patients were taken who were aged between 50 and 60 years old with the same exercise protocol. The EF of patients that were initially 35 to 40 rose by 40 to 50 in three months, and the patients were far more active. The study, which was initially meant to study diabetes mellitus, was slowly drifting towards cardiac insufficiency benefits, therefore we decided to move our work further.

Safety

The normal time to be taken by the abdominal muscle rectus abdominous to contract was between 200 and 250 milliseconds, which of course was dependent on the physical condition of every individual. This resulted in mild abstraction during systole when the abdominal muscle rectus abdominous contracted, but as the contraction and release of rectus abdominous was rhythmic, it was noticed that when the rectus abdominous contracted during the diastole the amplitude of the SpO2 rose to that of systolic.

To decrease the obstruction patients were attached to the cardiac monitor and were asked to contract during the beep of the monitor, this gave a perfect waveform, but it was very difficult maintaining the rhythm. We were advised of a similar study for refractory angina, which was called the ECP or the External Counter Pulsation. This did not meet our requirements, as unlike the contraction of the abdominal muscle rectus abdominous, which took 200 to 250 milliseconds, we found the ECP took almost 500 milliseconds in the diastolic phase. This was way beyond the requirement of our study, and also no randomized controlled trials examined the effects of ECP in the treatment of refractory angina.

Only one randomized controlled trial examined the effects of ECP in the treatment of CHF. The Prospective Evaluation of External Counterpulsation in Congestive Heart Failure (PEECH) study randomized 187 patients with mild or moderate heart failure to receive either ECP treatment in addition to optimal pharmacotherapy or pharmacotherapy alone.

Conclusion

The situation wanted something that could complete the contraction in a minimum of 200 to 250 milliseconds. The search for this need began, and we took it upon ourselves to design such a piece of equipment that met these needs.

The IECP was born.

ECP device SL-200

WARNING

If you are a cardiac insufficiency patient, we would advise you not to do Kapalbhati without a doctor's presence or advice. The above may not be considered medical advice. Your doctor is the best judge of your condition. Consult your doctor.

From our technical team

A commitment to Quality

Our technical section at TMC says::

At TMC, producing therapeutic equipment is part of our heritage. Our 25 years of experience and know-how provide invaluable benefits for our production facility in Ukraine, as well as in our close cooperation with our global dealers. We have chosen to work with only a few dealers that agree to our commitment to high quality, either in products or services.

We have a comprehensive quality-control programme based on the ISO 13485 and ISO 9000 standards… We have our own quality control department, and they ensure that our detailed guidelines are followed all the way through the production process and make sure that the final products are fully checked before leaving the assembly floor.

The equipment manufactured by us is a result of our in-house dedicated R & D department. Our latest product, the IECP Model: SL-200, is based on highly responsive velocity technology and is the best in the world. The history of IECP is short and sweet, but the result of this development is huge. You can read the history here...

Our new product yet to be launched for commercial production is the ACMP ( Activated cell management protocol). This will benefit the field of Oncology, as the target is to have a permanent remission period for cancer patients. We are working very hard on it.

If you want to send a message, please Click-here...

 

Our IECP Devices

TMC - Brisk

Volume based

TMC SL-100

Volume based

TMC SL-200

Velosity based

TMC SL-200e

Velosity based